Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study
The present study has been directed to investigate Ursodeoxycholic Acid (UDCA) effect in children, to reduce the high Liver transaminases induced by Anticonvulsant drugs (drug induced hepatitis). This idea has been driven from Cytoprotective and antioxidant properties of UDCA to be used in drug indu...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2015-06-01
|
| Series: | Acta Medica Iranica |
| Subjects: | |
| Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/4878 |
| _version_ | 1818827129635209216 |
|---|---|
| author | Masoumeh Asgarshirazi Mamak Shariat Hosein Dalili Zarrin Keihanidoost |
| author_facet | Masoumeh Asgarshirazi Mamak Shariat Hosein Dalili Zarrin Keihanidoost |
| author_sort | Masoumeh Asgarshirazi |
| collection | DOAJ |
| description | The present study has been directed to investigate Ursodeoxycholic Acid (UDCA) effect in children, to reduce the high Liver transaminases induced by Anticonvulsant drugs (drug induced hepatitis). This idea has been driven from Cytoprotective and antioxidant properties of UDCA to be used in drug induced inflammation in Liver. Twenty two epileptic patients aged between 4 mo - 3 yr whom were under anticonvulsant therapy with drugs such as valperoic acid, primidone, levetiracetam, Phenobarbital or any combination of them and had shown Liver transaminases rise , after rule out of Viral-Autoimmune, Metabolic and Anatomic causes, have been prescribed UDCA in dose of 10-15 mg/kg/day, at least for 6 months. Any patient who have shown confusing factors such as genetic disorders with liver involvement or spontaneous decline in enzymes or had not treatment compliance has been excluded from the study. Transaminases range changes as well as Probable side effects of the drug have been monitored. The results indicated that UDCA is effective and well tolerable in the children with drug induced hyper transaminasemia. No side effect has been seen and recorded in this study. Based on this study and its results, we recommend UDCA as a safe and effective choice in drug induced hepatotoxicities. |
| first_indexed | 2024-12-19T00:38:39Z |
| format | Article |
| id | doaj.art-503e975f64c4430786a50cb5db23914c |
| institution | Directory Open Access Journal |
| issn | 0044-6025 1735-9694 |
| language | English |
| last_indexed | 2024-12-19T00:38:39Z |
| publishDate | 2015-06-01 |
| publisher | Tehran University of Medical Sciences |
| record_format | Article |
| series | Acta Medica Iranica |
| spelling | doaj.art-503e975f64c4430786a50cb5db23914c2022-12-21T20:44:41ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942015-06-015364831Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot StudyMasoumeh Asgarshirazi0Mamak Shariat1Hosein Dalili2Zarrin Keihanidoost3Department of Pediatric, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Maternal Fetal & Neonatal Research Center, Tehran University of Medical Sciences, Tehran, Iran.Breastfeeding Research Center, Tehran University of Medical Sciences, Tehran, Iran.Department of Pediatric, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.The present study has been directed to investigate Ursodeoxycholic Acid (UDCA) effect in children, to reduce the high Liver transaminases induced by Anticonvulsant drugs (drug induced hepatitis). This idea has been driven from Cytoprotective and antioxidant properties of UDCA to be used in drug induced inflammation in Liver. Twenty two epileptic patients aged between 4 mo - 3 yr whom were under anticonvulsant therapy with drugs such as valperoic acid, primidone, levetiracetam, Phenobarbital or any combination of them and had shown Liver transaminases rise , after rule out of Viral-Autoimmune, Metabolic and Anatomic causes, have been prescribed UDCA in dose of 10-15 mg/kg/day, at least for 6 months. Any patient who have shown confusing factors such as genetic disorders with liver involvement or spontaneous decline in enzymes or had not treatment compliance has been excluded from the study. Transaminases range changes as well as Probable side effects of the drug have been monitored. The results indicated that UDCA is effective and well tolerable in the children with drug induced hyper transaminasemia. No side effect has been seen and recorded in this study. Based on this study and its results, we recommend UDCA as a safe and effective choice in drug induced hepatotoxicities.https://acta.tums.ac.ir/index.php/acta/article/view/4878Ursodeoxycholic acidLiver transaminasesDrug induced hepatitisAnticonvulsant drugs |
| spellingShingle | Masoumeh Asgarshirazi Mamak Shariat Hosein Dalili Zarrin Keihanidoost Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study Acta Medica Iranica Ursodeoxycholic acid Liver transaminases Drug induced hepatitis Anticonvulsant drugs |
| title | Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study |
| title_full | Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study |
| title_fullStr | Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study |
| title_full_unstemmed | Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study |
| title_short | Ursodeoxycholic Acid Can Improve Liver Transaminase Quantities in Children with Anticonvulsant Drugs Hepatotoxicity: a Pilot Study |
| title_sort | ursodeoxycholic acid can improve liver transaminase quantities in children with anticonvulsant drugs hepatotoxicity a pilot study |
| topic | Ursodeoxycholic acid Liver transaminases Drug induced hepatitis Anticonvulsant drugs |
| url | https://acta.tums.ac.ir/index.php/acta/article/view/4878 |
| work_keys_str_mv | AT masoumehasgarshirazi ursodeoxycholicacidcanimprovelivertransaminasequantitiesinchildrenwithanticonvulsantdrugshepatotoxicityapilotstudy AT mamakshariat ursodeoxycholicacidcanimprovelivertransaminasequantitiesinchildrenwithanticonvulsantdrugshepatotoxicityapilotstudy AT hoseindalili ursodeoxycholicacidcanimprovelivertransaminasequantitiesinchildrenwithanticonvulsantdrugshepatotoxicityapilotstudy AT zarrinkeihanidoost ursodeoxycholicacidcanimprovelivertransaminasequantitiesinchildrenwithanticonvulsantdrugshepatotoxicityapilotstudy |